Compare JFrog Ltd. Ordinary Shares (FROG) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JFrog Ltd. Ordinary Shares vs Immunovant Inc. Common Stock — how do they compare? JFrog Ltd. Ordinary Shares trades at $97.61 (market cap $12.10B), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: JFrog Ltd. Ordinary Shares is the larger of the two by market cap, and JFrog Ltd. Ordinary Shares is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JFrog Ltd. Ordinary Shares for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| FROG | IMVT | |
|---|---|---|
Market Cap | $12.10B | $6.62B |
Volume | 773,694 | 1,131,364 |
Sector | Technology | Health |
52-Week High | $104.03 | $44.96 |
52-Week Low | $34.75 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $11.29B | $5.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JFrog Ltd. Ordinary Shares
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
